Please try another search
For the three months ended 31 December 2018, Avant Diagnostics Inc revenues was not reported. Net loss applicable to common stockholders increased 69% to $452K. Higher net loss reflects Professional fees increase from $113K to $241K (expense), Gain on other comprehensive income decrease from $37K (income) to $0K, General and administrative increase of 12% to $277K (expense).
Period Ending: | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 |
Operating Income | -0.52 | -0.8 | -0.79 | -0.36 |
Net Income | -0.45 | -0.83 | -0.95 | -0.32 |
Period Ending: | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|
Total Assets | 4.91 | 4.82 | 5.15 | 5.03 |
Total Liabilities | 3.03 | 2.75 | 2.69 | 4.2 |
Total Equity | 1.88 | 2.07 | 2.47 | 0.82 |
Period Ending: | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -0.3 | -3.03 | -2.37 | 0.05 |
Cash From Investing Activities | 0.07 | -0.01 | 0.01 | 0.05 |
Cash From Financing Activities | 0.26 | 3.06 | 2.64 | -0.03 |
Net Change in Cash | 0.03 | 0.03 | 0.27 | 0.07 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review